Open AccessThird International Biannual Evolution and Cancer Conference (Evolutionary Trade‐offs and Clinical Consequences) Meeting report. San Francisco, CA, USA. 10–13 December 2015
Author(s) -
Roche Benjamin,
Thomas Frédéric
Publication year - 2016
Publication title -
evolutionary applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.776
H-Index - 68
ISSN - 1752-4571
DOI - 10.1111/eva.12359
Subject(s) - cancer , evolutionary medicine , disease , darwinism , epigenetics , evolutionary developmental biology , biology , evolutionary biology , medicine , genetics , pathology , gene
International audienceDespite recent notable progress in medical sciences, cancer remains a leading cause of human death worldwide, accounting for about one-quarter of human deaths in wealthy countries and about one-eighth worldwide (Ferlay et al. 2010). In fact, the progress in cancer research has been slower compared with that achieved related to other pathologies, such as cardiovascular disorders. This is mainly because of the enormous complexity of this disease, which exhibits sophisticated cellular mechanisms that are the targets of evolutionary processes driven by random genetic and epigenetic mutations